Loading...

Owens & Minor

NYSE:OMI
Snowflake Description

Fair value with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
OMI
NYSE
$216M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. The last earnings update was 51 days ago. More info.


Add to Portfolio Compare Print
  • Owens & Minor has significant price volatility in the past 3 months.
OMI Share Price and Events
7 Day Returns
1.5%
NYSE:OMI
1.8%
US Healthcare
0.9%
US Market
1 Year Returns
-78.7%
NYSE:OMI
-2.8%
US Healthcare
9.6%
US Market
OMI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Owens & Minor (OMI) 1.5% -17.5% -54.9% -78.7% -90.6% -89.4%
US Healthcare 1.8% -5.2% -9.7% -2.8% 13.1% 63.8%
US Market 0.9% 4.6% 10.9% 9.6% 39% 47.2%
1 Year Return vs Industry and Market
  • OMI underperformed the Healthcare industry which returned -2.8% over the past year.
  • OMI underperformed the Market in United States of America which returned 9.6% over the past year.
Price Volatility
OMI
Industry
5yr Volatility vs Market

Value

 Is Owens & Minor undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Owens & Minor to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Owens & Minor.

NYSE:OMI Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 9 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 14.7%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:OMI
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.72
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.716 (1 + (1- 21%) (766.76%))
3.715
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (2 * 5.96%)
14.65%

Discounted Cash Flow Calculation for NYSE:OMI using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Owens & Minor is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NYSE:OMI DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 14.65%)
2019 69.57 Analyst x4 60.68
2020 69.51 Analyst x4 52.88
2021 73.00 Analyst x1 48.44
2022 75.20 Est @ 3.02% 43.52
2023 77.41 Est @ 2.93% 39.08
2024 79.63 Est @ 2.87% 35.06
2025 81.88 Est @ 2.83% 31.45
2026 84.17 Est @ 2.8% 28.20
2027 86.51 Est @ 2.78% 25.28
2028 88.90 Est @ 2.76% 22.66
Present value of next 10 years cash flows $387.24
NYSE:OMI DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $88.90 × (1 + 2.73%) ÷ (14.65% – 2.73%)
$766.19
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $766.19 ÷ (1 + 14.65%)10
$195.25
NYSE:OMI Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $387.24 + $195.25
$582.49
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $582.49 / 63.02
$9.24
NYSE:OMI Discount to Share Price
Calculation Result
Value per share (USD) From above. $9.24
Current discount Discount to share price of $3.43
= -1 x ($3.43 - $9.24) / $9.24
62.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Owens & Minor is available for.
Intrinsic value
>50%
Share price is $3.43 vs Future cash flow value of $9.24
Current Discount Checks
For Owens & Minor to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Owens & Minor's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Owens & Minor's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Owens & Minor's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Owens & Minor's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:OMI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-7.28
NYSE:OMI Share Price ** NYSE (2019-04-25) in USD $3.43
United States of America Healthcare Industry PE Ratio Median Figure of 53 Publicly-Listed Healthcare Companies 21.81x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.28x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Owens & Minor.

NYSE:OMI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:OMI Share Price ÷ EPS (both in USD)

= 3.43 ÷ -7.28

-0.47x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Owens & Minor is loss making, we can't compare its value to the US Healthcare industry average.
  • Owens & Minor is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Owens & Minor's expected growth come at a high price?
Raw Data
NYSE:OMI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.47x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts
134.8%per year
United States of America Healthcare Industry PEG Ratio Median Figure of 40 Publicly-Listed Healthcare Companies 1.52x
United States of America Market PEG Ratio Median Figure of 2,113 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Owens & Minor, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Owens & Minor's assets?
Raw Data
NYSE:OMI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $8.32
NYSE:OMI Share Price * NYSE (2019-04-25) in USD $3.43
United States of America Healthcare Industry PB Ratio Median Figure of 92 Publicly-Listed Healthcare Companies 2.39x
United States of America Market PB Ratio Median Figure of 5,185 Publicly-Listed Companies 1.92x
NYSE:OMI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:OMI Share Price ÷ Book Value per Share (both in USD)

= 3.43 ÷ 8.32

0.41x

* Primary Listing of Owens & Minor.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Owens & Minor is good value based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Owens & Minor's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Owens & Minor has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Owens & Minor expected to perform in the next 1 to 3 years based on estimates from 9 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
134.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Owens & Minor expected to grow at an attractive rate?
  • Owens & Minor's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Owens & Minor's earnings growth is expected to exceed the United States of America market average.
  • Owens & Minor's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:OMI Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:OMI Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts 134.8%
NYSE:OMI Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts 0.4%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 7.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.5%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:OMI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:OMI Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 9,987 134 28 4
2020-12-31 9,867 117 2 9
2019-12-31 9,877 121 3 9
NYSE:OMI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 9,839 116 -437
2018-09-30 9,686 174 -153
2018-06-30 9,555 186 -141
2018-03-31 9,362 101 61
2017-12-31 9,318 57 72
2017-09-30 9,297 49 76
2017-06-30 9,378 62 95
2017-03-31 9,596 116 102
2016-12-31 9,723 188 108
2016-09-30 9,843 208 113
2016-06-30 9,899 66 111
2016-03-31 9,838 146 108

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Owens & Minor's earnings are expected to grow significantly at over 20% yearly.
  • Owens & Minor's revenue is expected to grow by 0.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:OMI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below

All data from Owens & Minor Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:OMI Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 0.45 0.45 0.45 1.00
2020-12-31 0.08 0.34 -0.35 3.00
2019-12-31 0.14 0.23 0.05 2.00
NYSE:OMI Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -7.28
2018-09-30 -2.54
2018-06-30 -2.36
2018-03-31 1.02
2017-12-31 1.20
2017-09-30 1.26
2017-06-30 1.57
2017-03-31 1.69
2016-12-31 1.76
2016-09-30 1.83
2016-06-30 1.80
2016-03-31 1.74

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Owens & Minor is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Owens & Minor's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Owens & Minor has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Owens & Minor performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Owens & Minor's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Owens & Minor does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Owens & Minor's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Owens & Minor's 1-year growth to the US Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Owens & Minor's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Owens & Minor Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:OMI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 9,838.71 -437.01 1,261.75
2018-09-30 9,685.56 -152.52 1,184.97
2018-06-30 9,554.65 -141.35 1,119.41
2018-03-31 9,362.28 61.02 1,063.65
2017-12-31 9,318.28 71.73 1,016.98
2017-09-30 9,296.80 75.87 978.83
2017-06-30 9,378.44 94.81 959.09
2017-03-31 9,596.21 102.33 965.39
2016-12-31 9,723.43 107.64 970.42
2016-09-30 9,842.98 112.59 977.12
2016-06-30 9,899.05 110.97 982.77
2016-03-31 9,837.54 107.56 986.81
2015-12-31 9,772.95 102.48 993.78
2015-09-30 9,776.85 84.57 987.76
2015-06-30 9,691.31 63.70 972.18
2015-03-31 9,575.00 59.39 951.06
2014-12-31 9,440.18 65.91 984.10
2014-09-30 9,266.89 79.81 904.87
2014-06-30 9,151.31 100.54 884.84
2014-03-31 9,081.53 109.54 871.55
2013-12-31 9,071.53 110.14 863.66
2013-09-30 9,038.11 107.16 853.03
2013-06-30 8,947.46 103.82 807.00
2013-03-31 8,896.83 105.03 744.74
2012-12-31 8,868.32 108.25 682.60
2012-09-30 8,779.11 107.24 621.72
2012-06-30 8,775.98 115.89 609.22

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Owens & Minor has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Owens & Minor has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Owens & Minor improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Owens & Minor's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Owens & Minor has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Owens & Minor's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Owens & Minor's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Owens & Minor is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Owens & Minor's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Owens & Minor's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Owens & Minor Company Filings, last reported 3 months ago.

NYSE:OMI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 518.42 1,657.46 103.37
2018-09-30 792.41 1,640.46 124.89
2018-06-30 802.21 1,669.48 118.19
2018-03-31 1,018.92 897.07 87.63
2017-12-31 1,015.48 900.74 104.52
2017-09-30 1,003.78 917.26 98.42
2017-06-30 993.57 579.12 57.07
2017-03-31 969.96 564.15 127.17
2016-12-31 960.04 564.58 185.49
2016-09-30 986.68 566.47 213.10
2016-06-30 996.30 566.96 138.95
2016-03-31 1,004.92 567.71 190.32
2015-12-31 992.59 568.50 161.02
2015-09-30 986.10 574.03 125.25
2015-06-30 977.13 574.62 200.97
2015-03-31 968.27 574.61 159.06
2014-12-31 990.84 608.55 56.77
2014-09-30 1,007.52 766.28 610.15
2014-06-30 1,031.39 219.10 92.03
2014-03-31 1,033.17 214.83 182.37
2013-12-31 1,025.04 216.24 101.91
2013-09-30 1,006.32 214.42 153.79
2013-06-30 989.82 214.68 207.83
2013-03-31 977.55 214.24 218.56
2012-12-31 973.66 217.59 97.89
2012-09-30 960.06 214.80 79.67
2012-06-30 949.96 212.03 224.94
  • Owens & Minor's level of debt (319.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (21.1% vs 319.7% today).
  • Debt is not well covered by operating cash flow (7%, less than 20% of total debt).
  • Owens & Minor is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Owens & Minor's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Owens & Minor has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Owens & Minor's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.29%
Current annual income from Owens & Minor dividends. Estimated to be 4.67% next year.
If you bought $2,000 of Owens & Minor shares you are expected to receive $6 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Owens & Minor's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.39%).
  • Owens & Minor's dividend is below the markets top 25% of dividend payers in United States of America (3.61%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:OMI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2008 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:OMI Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 0.28 4.00
2020-12-31 0.20 7.00
2019-12-31 0.01 5.00
NYSE:OMI Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-02-19 0.010 0.225
2018-11-05 0.300 4.049
2018-10-31 0.300 3.392
2018-08-07 1.040 6.585
2018-05-10 1.040 6.136
2018-01-31 1.040 6.505
2017-11-01 1.030 5.261
2017-08-01 1.030 3.661
2017-05-04 1.030 3.212
2017-02-14 1.030 2.961
2016-11-01 1.020 2.925
2016-08-02 1.020 3.011
2016-05-05 1.020 2.778
2016-02-08 1.020 2.621
2015-10-27 1.010 2.816
2015-07-27 1.010 2.956
2015-04-29 1.010 2.986
2015-02-17 1.010 2.963
2014-10-27 1.000 2.895
2014-07-28 1.000 2.989
2014-05-01 1.000 2.928
2014-02-10 1.000 2.871
2013-11-04 0.960 2.633
2013-07-29 0.960 2.709
2013-04-25 0.960 2.813
2013-02-11 0.960 3.057
2012-10-18 0.880 3.032
2012-07-18 0.880 3.045
2012-04-26 0.880 3.014
2012-02-06 0.880 2.943
2011-10-20 0.800 2.734
2011-07-21 0.800 2.736
2011-04-28 0.800 2.350
2011-02-07 0.800 2.524
2010-10-21 0.708 2.432
2010-07-23 0.708 2.581
2010-04-29 0.708 2.413
2010-04-26 0.708 2.236
2010-02-08 0.707 2.306
2009-10-21 0.613 2.221
2009-07-22 0.613 2.054

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Owens & Minor is not paying a notable dividend for United States of America, therefore no need to check if the payments are stable.
  • Owens & Minor is not paying a notable dividend for United States of America, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Owens & Minor's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Owens & Minor's dividends as it is not paying a notable one for United States of America.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.4x coverage).
X
Income/ dividend checks
We assess Owens & Minor's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Owens & Minor afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Owens & Minor has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Owens & Minor's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ed Pesicka
AGE 50
TENURE AS CEO 0.1 years
CEO Bio

Mr. Edward A. Pesicka, also known as Ed, has been the Chief Executive Officer, President and Director of Owens & Minor, Inc. since March 4, 2019. Mr. Pesicka served as Chief Commercial Officer of Thermo Fisher Scientific, Inc. from January 2014 and as its Senior Vice President from July 2008 to March 31, 2015. Mr. Pesicka served as the President of Customer Channels at Thermo Fisher Scientific, Inc. from July 2008 to January 2014. He served as the President of Research Market of Thermo Fisher Scientific, Inc. from November 2006 to July 2008. He served as Vice President and General Manager of U.S. research business at Thermo Fisher from January 2004 to November 2006. Mr. Pesicka served as a Director at Dionex Corp. from 2011 to May 17, 2011. He holds an Master’s of Business Administration degree in finance from the Weatherhead School of Management at Case Western Reserve University and a Bachelor’s degree in accounting and business administration from Muskingum College.

CEO Compensation
  • Insufficient data for Ed to compare compensation growth.
  • Insufficient data for Ed to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Owens & Minor management team in years:

0.8
Average Tenure
50.5
Average Age
  • The average tenure for the Owens & Minor management team is less than 2 years, this suggests a new team.
Management Team

Robert Snead

TITLE
Executive VP & CFO
COMPENSATION
$1M
AGE
41
TENURE
0.8 yrs

Nick Pace

TITLE
Executive VP
COMPENSATION
$2M
AGE
47
TENURE
3.3 yrs

Chris Lowery

TITLE
President of Global Products
COMPENSATION
$4M
AGE
54
TENURE
0.3 yrs

Ed Pesicka

TITLE
President
AGE
50
TENURE
0.1 yrs

Mike Lowry

TITLE
Senior VP
COMPENSATION
$311K
AGE
56
TENURE
0.8 yrs

Joseph Pekala

TITLE
Senior VP & Chief Information Officer
AGE
47
TENURE
0.3 yrs

Erika Davis

TITLE
Senior VP & Chief Administrative Officer
COMPENSATION
$1M
AGE
54
TENURE
2.5 yrs

Chuck Graves

TITLE
Director of Finance & Investor Relations

Jenny Graves

TITLE
Vice President of Global Corporate Communications

Shana Neal

TITLE
Senior VP & Chief Human Resources Officer
AGE
51
TENURE
1.1 yrs
Board of Directors Tenure

Average tenure and age of the Owens & Minor board of directors in years:

6
Average Tenure
67.5
Average Age
  • The tenure for the Owens & Minor board of directors is about average.
Board of Directors

Bob Sledd

TITLE
Chairman
COMPENSATION
$3M
AGE
65
TENURE
0.4 yrs

Ed Pesicka

TITLE
President
AGE
50
TENURE
0.1 yrs

G. Minor

TITLE
Chairman Emeritus
COMPENSATION
$367K
AGE
77
TENURE
6 yrs

Craig Smith

TITLE
Chairman Emeritus
COMPENSATION
$45K
AGE
66

Lem Lewis

TITLE
Independent Director
COMPENSATION
$269K
AGE
71
TENURE
7.9 yrs

Martha Marsh

TITLE
Independent Director
COMPENSATION
$264K
AGE
69
TENURE
6.5 yrs

Barbara Hill

TITLE
Independent Director
COMPENSATION
$256K
AGE
66
TENURE
2.2 yrs

Anne Whittemore

TITLE
Lead Independent Director
COMPENSATION
$281K
AGE
71
TENURE
5.3 yrs

Eddie Moore

TITLE
Independent Director
COMPENSATION
$248K
AGE
70
TENURE
14 yrs

John Gerdelman

TITLE
Independent Director
COMPENSATION
$245K
AGE
65
TENURE
8.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
28. Aug 18 Sell Charles Colpo Individual 27. Aug 18 27. Aug 18 -11,000 $16.87 $-185,614
23. Aug 18 Sell Erika Davis Individual 21. Aug 18 21. Aug 18 -10,000 $16.59 $-165,857
23. Aug 18 Sell Geoffrey Marlatt Individual 21. Aug 18 21. Aug 18 -11,405 $16.27 $-185,559
22. Aug 18 Sell Erika Davis Individual 20. Aug 18 20. Aug 18 -12,500 $16.25 $-203,063
21. Aug 18 Sell Charles Colpo Individual 20. Aug 18 20. Aug 18 -12,000 $16.31 $-195,720
17. Aug 18 Sell Geoffrey Marlatt Individual 16. Aug 18 16. Aug 18 -8,516 $15.50 $-132,015
X
Management checks
We assess Owens & Minor's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Owens & Minor has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Who Has Been Selling Owens & Minor, Inc. (NYSE:OMI) Shares?

So shareholders might well want to know whether insiders have been buying or selling shares in Owens & Minor, Inc. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … Owens & Minor Insider Transactions Over The Last Year

Simply Wall St -

Is It Too Late To Consider Buying Owens & Minor, Inc. (NYSE:OMI)?

As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock? … However, could the stock still be trading at a relatively cheap price. … Let’s examine Owens & Minor’s valuation and outlook in more detail to determine if there’s still a bargain opportunity

Simply Wall St -

Why Owens & Minor, Inc.’s (NYSE:OMI) Return On Capital Employed Might Be A Concern

Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Understanding Return On Capital Employed (ROCE). … ROCE measures the amount of pre-tax profits a company can generate from the capital employed in its business.

Simply Wall St -

One Thing To Remember About The Owens & Minor, Inc. (NYSE:OMI) Share Price

(NYSE:OMI), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

Should Owens & Minor Inc (NYSE:OMI) Be Part Of Your Income Portfolio?

Historically, Owens & Minor Inc (NYSE:OMI) has been paying a dividend to shareholders. … Let's take a look at Owens & Minor in more detail. … Check out our latest analysis for Owens & Minor

Simply Wall St -

Why Owens & Minor Inc (NYSE:OMI) Could Be Worth Watching

Owens & Minor Inc (NYSE:OMI), which is in the healthcare business, and is based in United States,. … A question to answer is whether Owens & Minor's current trading price of $14.2 reflective of the actual value of the? … Let’s take a look at Owens & Minor’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change

Simply Wall St -

Check If Insiders Are Selling Owens & Minor Inc (NYSE:OMI)

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare services company in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. … Owens & Minor's insiders have divested from. … A well-known argument is that insiders divesting from their own companies’ shares sends a pessimistic signal

Simply Wall St -

What Are Analysts Saying About the future of Owens & Minor Inc's (NYSE:OMI)?

Owens & Minor Inc (NYSE:OMI) to … earnings growth of 33.82% annualised … it's necessary to take a moment

Simply Wall St -

Owens & Minor Inc (NYSE:OMI): What Does It Mean For Your Portfolio?

Generally, an investor should consider two types of risk that impact the market value of OMI. … The second type is market risk, one that you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks in the market. … A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one.

Simply Wall St -

With An ROE Of 6.10%, Has Owens & Minor Inc's (NYSE:OMI) Management Done Well?

and want to better understand how you can grow your money by investing in Owens & Minor Inc (NYSE:OMI). … Owens & Minor Inc (NYSE:OMI) generated a below-average return on equity of 6.10% in the past 12 months, while its industry returned 13.80%. … Knowing these components can change your views on OMI's below-average returns

Simply Wall St -

Company Info

Description

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; various programs to provide logistics and marketing solutions to its suppliers; and contract logistics services to the pharmaceutical, biotechnology, and medical device industries offering a range of supply chain logistics services to manufacturers. In addition, it offers business services comprising order-to-cash, re-labeling, customer service, and returns management; and warehousing and transportation services consisting of storage, controlled-substance handling, cold-chain, emergency and export delivery, inventory management, and pick and pack services. The Global Products segment manufactures and sources medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians’ practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.

Details
Name: Owens & Minor, Inc.
OMI
Exchange: NYSE
Founded: 1882
$216,164,499
63,021,720
Website: http://www.owens-minor.com
Address: Owens & Minor, Inc.
9120 Lockwood Boulevard,
Mechanicsville,
Virginia, 23116,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE OMI Common Stock New York Stock Exchange US USD 14. Dec 1972
DB 6OM Common Stock Deutsche Boerse AG DE EUR 14. Dec 1972
Number of employees
Current staff
Staff numbers
17,900
Owens & Minor employees.
Industry
Health Care Distributors
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/26 01:42
End of day share price update: 2019/04/25 00:00
Last estimates confirmation: 2019/04/23
Last earnings filing: 2019/03/06
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.